Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times.
Saved in:
| Title: | Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times. |
|---|---|
| Authors: | Zhao YJ (AUTHOR), Wee HL (AUTHOR), Au WL (AUTHOR), Seah SH (AUTHOR), Luo N (AUTHOR), Li SC (AUTHOR), Tan LC (AUTHOR) |
| Source: | Parkinsonism & Related Disorders. Mar2011, Vol. 17 Issue 3, p194-197. 4p. |
| Database: | Academic Search Ultimate |
| ISSN: | 13538020 |
|---|---|
| DOI: | 10.1016/j.parkreldis.2010.11.010 |
